Ginkgo Bioworks DNA Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's common stock, shares authorized (in shares)?
- Ginkgo Bioworks (DNA) reported common stock, shares authorized (in shares) of $15.8B in Q1 2026.
- How has Ginkgo Bioworks's common stock, shares authorized (in shares) changed year-over-year?
- Ginkgo Bioworks's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $15.8B to $15.8B.
- What is the long-term trend for Ginkgo Bioworks's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $15.8B to $15.8B.